文献速递艾滋病与性传播感染

HIV感染者接受抗逆转录病毒治疗后超重与肥胖的相关因素:社会临床、炎症与代谢标志物

Factors Associated With Being Overweight and Obesity in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy: Socioclinical, Inflammation, and Metabolic Markers.
PubMed 文献 · J Infect Dis · 2021-01-01

该研究基于COPANA队列中158例起始cART时BMI正常且36个月病毒学抑制的HIV感染者,评估36个月时超重或肥胖的相关因素。20%的感染者出现超重或肥胖,多因素分析显示基线较高BMI、撒哈拉以南非洲出生、同居、较高sTNFR2及较低脂联素与结局相关。结论提示cART期间体重增加是多因素的,应重点关注来自撒哈拉以南非洲的移民,单核细胞激活和脂肪细胞功能障碍影响体重调节。

要点

  • 36个月cART后20%的正常BMI HIV感染者转为超重或肥胖。
  • 撒哈拉以南非洲出生、同居、较高sTNFR2和较低脂联素与体重增加相关。
  • 应对来自撒哈拉以南非洲的HIV感染者给予特别关注。

核心结论

  • cART期间体重增加是多因素的,基线炎症和代谢标志物及社会临床因素与超重或肥胖相关。

研究设计与样本

  • COPANA队列中158例起始cART时BMI正常(18.5-24.9)且36个月病毒学抑制(病毒载量<50 copies/mL)的HIV感染者,评估临床、免疫病毒学、社会经济、炎症和代谢标志物,采用多因素logistic回归分析36个月时超重或肥胖的相关因素。

主要发现

  • 36个月cART后,158例中32例(20%)变为超重或肥胖,其中女性21%,法国出生65%,撒哈拉以南非洲出生23%,起始cART时中位BMI为22(IQR 21-23)。
  • 调整后,较高BMI、撒哈拉以南非洲出生、同居、较高可溶性肿瘤坏死因子受体2和较低脂联素浓度与变为超重或肥胖相关。

关键数值与推荐

  • 超重定义为BMI 25-29.9,肥胖定义为BMI≥30。
  • 病毒学抑制定义为病毒载量<50 copies/mL。
  • 正常体重定义为BMI 18.5-24.9。

临床怎么用

  • 对起始cART时BMI正常者应关注体重变化,尤其来自撒哈拉以南非洲的移民。
  • 基线sTNFR2和脂联素等标志物可能有助于识别体重增加高风险者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated the association between socioclinical, inflammatory, and metabolic markers and weight gain in people with human immunodeficiency virus (HIV) on combination antiretroviral therapy (cART). METHODS: Individuals from the COPANA cohort of normal weight (body mass index [BMI], 18.5-24.9 [ calculated as weight in kilograms divided by height in meters squared) at cART initiation who achieved virological suppression (viral load, <50 copies/mL) and maintained it through 36 months of treatment were selected. Clinical, immunovirological, and socioeconomic data and inflammation (high-sensitivity C-reactive protein, CXCL10, CXCL8, interleukin 6, soluble tumor necrosis factor receptors 1 and 2, soluble CD14, and soluble CD16) and serum metabolic (glucose, insulin, lipid profile, adiponectin, and leptin) markers were assessed. Factors associated with becoming overweight (BMI, 25-29.9) or obese (BMI, ≥30) at 36 months were assessed using multivariate logistic regression models. RESULTS: After 36 months of cART, 32 of 158 people with HIV (20%) became overweight or obese (21% female; 65% born in France and 23% born in sub-Saharan Africa; median BMI at cART initiation, 22 [interquartile range, 21-23]). After adjustment, higher BMI, originating from sub-Saharan Africa, living in a couple, and higher soluble tumor necrosis factor receptor 2 and lower adiponectin concentrations at cART initiation were associated with becoming overweight or obese. CONCLUSION: Weight gain on cART is multifactorial. Special attention should be given to migrants from sub-Saharan Africa. Monocyte activation and adipocyte dysfunction at cART initiation affect weight regulation.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Goupil de Bouillé J, Vigouroux C, Plessis L, et al. Factors Associated With Being Overweight and Obesity in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy: Socioclinical, Inflammation, and Metabolic Markers. J Infect Dis. 2021. PMID: 33740044. doi:10.1093/infdis/jiab151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。